Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bcl-2 and Bax

Blood

Volumn 88, Issue 10, 1996, Pages 3987-3997

  Lisovsky, M ^b   Estrov, Z ^b   Zhang, X ^b   Consoli, U ^b   Sanchez Williams, G ^b   Snell, V ^b   Munker, R ^b   Goodacre, A ^b   Savchenko, V ^b   Andreeff, M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIGAND; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 10544226868     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3987.bloodjournal88103987     Document Type: Article

References (76)

1. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 9:383, 1992
2. d mice. Proc Soc Exp Biol Med 152:398, 1976
3. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W: CSF-1 deficiency in the oplop mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 20:1004, 1992
4. Rosnet O, Birnbaum D: Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncol 4:595,1993
5. Rosnet O, Mattei M-G, Marchetto S, Birnbaum D: Isolation and chromosomal localizalion of a novel fms-like tyrosine kinase gene. Genomics 9:380, 1991
6. Mattews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR: A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143, 1991
7. Rosnet O, Schiff C, Pebusque M-J, Marcetto S, Tonelle C, Toiron Y, Birg F, Birnbaum D: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82:1110, 1993
8. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Nail Acad Sci USA 91:459, 1994
9. Visser JWM, Rozemuller H, de Jong MO, Belyavsky A: The expression of cytokine receptors by purified hematopoietic stem cells. Stem Cells 119:49, 1993 (suppl 2)
10. Zeigler FC, Bennet BD, Jordan CT, Spencer SD, Baumhueter S, Carroll KJ, Hooley J, Bauer K, Matthews W: Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422, 1994
11. de Vries P, Brasel KA, McKenna HJ, Williams DE, Lyman SD: The role of flt3 ligand in early murine hematopoiesis. Blood 84:279a, 1994
12. Birg F, Courcoul M, Bardin F, Pebusque M-J, Marchetto S, Tabilio A, Mannoni P, Birnbaum D: Expression of the FMS/KIT like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 80:2584, 1992
13. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
14. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
15. Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckmann P, Copeland NG, Cleveland LS, Jenkins NA, Belmont JW, Davison BL: Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 10:149, 1995
16. Lisovsky M, Braun S, Ge Y, Takahira H, Lu Li, Savchenko V, Lyman SD, Broxmeyer HE: Flt3-Ligand production by human bone marrow stromal cells. Leukemia 18:1012, 1996
17. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li Z-H, Lyman SD: Flt3 ligand stimulates/costimulates the growth of myeloid stem/ progenitor cells. Exp Hematol 23:1121, 1995
18. Gabbianelli M, Pelosi E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C: Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem sells and proliferation of granulomonocytic precursors. Blood 86:1661, 1995
19. Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D: FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 86:2747, 1995
20. Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12 and other hematopoietic growth factors. J Exp Med 181:1357, 1995
21. dim cells. Blood 84:368a, 1994 (abstr, suppl 1)
22. Lyman SD, Brasel K, Rousseau A-M, Williams DE: The flt3 ligand: A hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12:99, 1994 (suppl 1)
23. Piacibello W, Fubini L, Sanavio F, Brizzi MF, Severino A, Garetto L, Stacchini A, Pegoraro L, Aglietta M: Effects of human flt3 ligand on myeloid leukemia cell growth: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 86:4105, 1995
24. DaSilva N, Hu Z-B, Ma W, Rosnet O, Birnbaum D, Drexler HG: Expression of the flt3 gene in human leukemia-lymphoma cell lines. Leukemia 8:885, 1994
25. Brasel K, Escobar S, Anderberg R, de Vries P, Grass H-J, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212, 1995
26. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
27. Brandt JE, Bhalla K, Hoffman R: Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83:1507, 1994
28. Oltvai Z, Milliman C, Korsmeyer S: Bcl-2 heterodimerizes in vivo with a concerved homologue, bax, that accelerates programmol/Led cell death. Cell 74:609, 1993
29. Boise L, Gonzales-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunez G, Thompson C: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
30. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bc12 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92:7834, 1995
31. Miltenyi S, Muller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231, 1990
32. Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig W-D, Zsebo K, Weite K: Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 80:1199, 1992
33. Lowenberg B, Van Potten WLJ, Touw I, Delwel R, Santini V: Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult myeloid leukemia. N Engl J Med 328:614, 1993
34. Buick RN, Till JE, McCulloch EA: A colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet 1:862, 1977
35. Minden MD, Buick RN, McCulloch EA: Separation of blast cells and T lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood 54:186, 1979
36. Freedman MH, Chan HSL, Chang L: Childhood erythroleukemia: Studies on pathogenesis using colony assays. Am J Pediatr Hematol Oncol 8:2, 1986
37. Andreeff M, Darzynkiewicz Z., Sharpless TK, Clarkson BD, Melamed MR: Discrimination of human leukemia subtypes by flow cytometric analyses of cellular DNA and RNA. Blood 55:282, 1980
38. Arends MJ, Morris RG, Wyllie H: Apoptosis: The role of endonuclease. Am J Pathol 136:593, 1990
39. Tiirikainen MI: Evaluation of red blood cell lysing solutions for the detection of intracellular antigens by flow cytometry. Cytometry 20:341, 1995
40. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 9:1191, 1995
41. Swat W, Ignatowicz L, Kisielow P: Detection of apoptosis of immol/Lature CD4+8+ thymocytes by flow cytometry. J Immunol Methods 137:79, 1991
42. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275, 1992
43. Broome EH, Dargan CM, Krajewski S, Reed JC: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 155:2311, 1995
44. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Feartures of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
45. Gallagher S, Winston SE, Fuller SA, Hurrell JGR: Immunoblotting and Imunodetection, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York, NY, Wiley, 1993, p10.8.1
46. Carlesso N, Pregno P, Gallo E, Pileri A, Zsebo KM, Ferrero D: Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 6:642, 1992
47. Bradbury D, Zhu Y-M, Russel N: Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukemia cells by granulocyte-macrophage colony-stimulating factor. Leukemia 8:786, 1994
48. Caseres-Cortes J, Rajotte D, Dumouchel J, Haddad P, Hoang T: Product of the steel locus suppresses apoptosis in hematopoietic cells. Comparison with pathways activated by granulocyte-macrophage colony-stimulating factor. J Biol Chem 269:12084, 1994
49. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer S: Bc12 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
50. Russel NH, Hunter AE, Bradbury D, Zhu YM, Keith F: Biological features of leukemic cells associated with autonomous growth and reduced survival in acute myeloblastic leukemia. Leuk Lymphoma 16:223, 1995
51. Lowenberg B, Touw IP: Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281, 1993
52. Sacs L, Lotem J: Control of programmol/Led cell death in normal and leukemic cells: New implications for therapy. Blood 82:15, 1993
53. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin D: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962, 1991
54. Deiwel R, Salem M, Pellens C, Dorssers L, Wagemaker G, Clark S, Lowenberg B: Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum free culture system. Blood 72:1944, 1988
55. Wang C, Koistinen P, Yang GS, Williams DE, Lyman SD, Minden MD, McCulloch EA: Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia. Leukemia 5:493, 1991
56. Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID: Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 80:60, 1992
57. Budel LM, Delwel R, van Buitten C, Hoogerbrugge H, Lowenberg B: Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: Effects of combinations with other cytokines. Leukemia 7:426, 1993
58. Lotem J, Cragoe EJ, Sachs L: Rescue from programmol/Led cell death in leukemic and normal myeloid cells. Blood 78:953, 1991
59. Han JH, Gileadi C, Rajapaksa, Kosek J, Greenberg PL: Modulation of apoptosis in human myeloid leukemic cells by GM-CSF. Exp Hematol 23:265, 1995
60. Lee A, Whyte MKB, Haslett C: Prolongation of in vitro life-span and functional longevity of neutrophils by inflammatory mediators acting through inhibition of apoptosis. J Leuk Biol 54:283, 1993
61. Stern M, Meagher L, Savil J, Haslett C: Apoptosis in human eosinophils. Programmol/Led cell death in the eosiniphil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 148:3543, 1992
62. Hockenbery D, Nunez G, Milliman G, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
63. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
64. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736, 1995
65. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733, 1995
66. Takayama S, Sato T, Krajewski S, Koshel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of Bag-1: A novel Bcl2-binding protein with anti-cell death activity. Cell 80:279, 1995
67. Yin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature 369:321, 1994
68. Hanada M, Aime-Sempe C, Sato T, Reed JC: Structure-function analysis of Bcl-2 protein identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 270:11962, 1995
69. Park JR, Bernstein ID, Hockenbery DM: Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86:868, 1995
70. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Gang Wang H, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323, 1994
71. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Della Porte G: Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291, 1992
72. Campos L, Rouault J-P, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud J-P, Guyotat D: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81, 3091, 1993
73. ++ cells by induction chemotherapy of AML. Blood 86:511a, 1995 (abstr, suppl 1)
74. Campos L, Sabido O, Rouault J-P, Guyotat D: Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84:595, 1994
75. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M: Interleukin 4 protects cronic lymphocytic leukemic B cells from death by apoplosis and upregulates Bcl-2 expression. J Exp Med 176:1319, 1992
76. Seki H, Kanegane H, Konno A, Ohta A, Ohta K, Yashie A, Taniguchi N, Miyawaki T: Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol 163:30, 1995